» Articles » PMID: 31637067

HIV-Associated Vacuolar Myelopathy and HIV-Associated Dementia As the Initial Manifestation of HIV/AIDS

Overview
Publisher Wiley
Date 2019 Oct 23
PMID 31637067
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-associated vacuolar myelopathy (HIV-VM) is the most common cause of spinal disease in HIV/AIDS. HIV-VM causes progressive spastic paraparesis, sensory ataxia, and autonomic dysfunction. It is a progressive myelopathy that shares features with subacute combined degeneration seen in vitamin B12 deficiency as well as other neurological diseases and can occur synchronously with HIV-associated dementia (HAD). Here, we describe a rare case in which a patient's initial presentation of HIV/AIDS was both HIV-VM and HAD. A fifty-three-year-old man presented with a six-month history of numerous falls due to progressive gait instability with associated memory loss, tremor, urinary retention, and impotence. His exam was significant for hyperreflexia and weakness in bilateral lower extremities, upgoing plantar reflex, dysmetria, and ataxic gait. MRI-brain was notable for nonspecific volume loss and diffusely increased T2 signal throughout the supratentorial white matter. Lumbar puncture showed isolated lymphocytic pleocytosis with all other CSF testing unremarkable. He ultimately tested positive for HIV-1, with a CD4 count of 157 cells/mm and a viral load of 874,000 copies/mL. He was diagnosed with HIV-VM and HAD which improved after several months of antiretroviral therapy. This case highlights the importance of considering HIV testing in a patient with a sensory neuropathy and/or progressive cognitive impairment.

Citing Articles

Degenerative cervical myelopathy in HIV: Rates of postoperative complications and revision following decompression surgery.

Seidel H, Benson D, Litvak A, Lee M, El Dafrawy M N Am Spine Soc J. 2025; 21:100577.

PMID: 40026323 PMC: 11872388. DOI: 10.1016/j.xnsj.2024.100577.


Myelopathy as the first manifestation of AIDS.

Li Y, Yang Q, Lin H, Zhou Q, Ge F, Shi J AIDS Res Ther. 2024; 21(1):102.

PMID: 39741336 PMC: 11689671. DOI: 10.1186/s12981-024-00695-4.


Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient.

Gough S, Borgetti S, Fernandes C IDCases. 2022; 29:e01567.

PMID: 35865083 PMC: 9294536. DOI: 10.1016/j.idcr.2022.e01567.


Neuropathogenesis of HIV and emerging therapeutic targets.

Siddiqui A, He C, Lee G, Figueroa A, Slaughter A, Robinson-Papp J Expert Opin Ther Targets. 2022; 26(7):603-615.

PMID: 35815686 PMC: 9887458. DOI: 10.1080/14728222.2022.2100253.


Magnetic resonance imaging evaluation of spinal cord lesions: what can we find? - Part 2. Inflammatory and infectious injuries.

Pereira R, Ribeiro B, Pereira T, Bahia P, Marchiori E Radiol Bras. 2021; 54(6):412-417.

PMID: 34866702 PMC: 8630953. DOI: 10.1590/0100-3984.2020.0128.


References
1.
Bizaare M, Dawood H, Moodley A . Vacuolar myelopathy: a case report of functional, clinical, and radiological improvement after highly active antiretroviral therapy. Int J Infect Dis. 2007; 12(4):442-4. DOI: 10.1016/j.ijid.2007.09.014. View

2.
Spudich S, Nilsson A, Lollo N, Liegler T, Petropoulos C, Deeks S . Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005; 5:98. PMC: 1299327. DOI: 10.1186/1471-2334-5-98. View

3.
Price R . Neurological complications of HIV infection. Lancet. 1996; 348(9025):445-52. DOI: 10.1016/S0140-6736(95)11035-6. View

4.
Sacktor N, Skolasky R, Seaberg E, Munro C, Becker J, Martin E . Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology. 2016; 86(4):334-40. PMC: 4776086. DOI: 10.1212/WNL.0000000000002277. View

5.
Sahoo S, Malhotra S . Dementia as a presenting symptom of HIV/AIDS: A patient report and review of the evidence. Asian J Psychiatr. 2017; 29:114-116. DOI: 10.1016/j.ajp.2017.05.003. View